Patients should also seek advice if they experience inadequate weight loss (less than 5% body weight after 6 months on the maintenance dose) as NICE guidance and the SmPC indicate treatment should be reviewed
The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday
[24] In May 2025, Greenfield partnered with 10X Health and OsteoStrong, producing a series of videos and marketing materials to promote the brands
Among GLP-1 RA ever-users, there was no increased risk in thyroid cancer with an increasing cumulative dose of GLP-1 RA
Preservatives (if included in the vial) may help, but their effectiveness also diminishes over time, especially once the seal is broken
We asked the Anesthesia Manual App: Should GLP-1R agonists be stopped preoperatively?